BR0008241A - Utilização de fanquinona para a preparação deuma composição farmacêutica para o tratamentode enfraquecimento de memória e método detratamento - Google Patents
Utilização de fanquinona para a preparação deuma composição farmacêutica para o tratamentode enfraquecimento de memória e método detratamentoInfo
- Publication number
- BR0008241A BR0008241A BR0008241-4A BR0008241A BR0008241A BR 0008241 A BR0008241 A BR 0008241A BR 0008241 A BR0008241 A BR 0008241A BR 0008241 A BR0008241 A BR 0008241A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- phanquinone
- pharmaceutical composition
- preparation
- memory impairment
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- VLPADTBFADIFKG-UHFFFAOYSA-N phanquone Chemical compound C1=CN=C2C(=O)C(=O)C3=NC=CC=C3C2=C1 VLPADTBFADIFKG-UHFFFAOYSA-N 0.000 title abstract 4
- 229960003606 phanquinone Drugs 0.000 title abstract 3
- 206010027175 memory impairment Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000969 carrier Substances 0.000 abstract 1
- 230000028252 learning or memory Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
"UTILIZAçãO DE FANQUINONA PARA A FABRICAçãO DE UMACOMPOSIçãO FARMACEUTICA PARA O TRATAMENTO DEENFRAQUECIMENTO DE MEMóRIA E MéTODO DETRATAMENTO." Sugere-se a administração de fanquinona(4,7-fenantrolina-5,6-diona) para o tratamento ou a prevenção deenfraquecimento de memória. Também sugere-se um método paramelhora do aprendizado ou da memória, o referido métodocompreendendo a administração de fanquinona, opcionalmentecom um ou mais portadores aceitáveis na farmacologia.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR99100005 | 1999-01-07 | ||
PCT/IB2000/000011 WO2000040244A1 (en) | 1999-01-07 | 2000-01-06 | Use of phanquinone for the treatment or prevention of memory impairment |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0008241A true BR0008241A (pt) | 2001-10-30 |
Family
ID=10943706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0008241-4A BR0008241A (pt) | 1999-01-07 | 2000-01-06 | Utilização de fanquinona para a preparação deuma composição farmacêutica para o tratamentode enfraquecimento de memória e método detratamento |
Country Status (17)
Country | Link |
---|---|
US (1) | US7030136B2 (pt) |
EP (1) | EP1140090B1 (pt) |
JP (1) | JP2002534386A (pt) |
AR (1) | AR022215A1 (pt) |
AT (1) | ATE285235T1 (pt) |
AU (1) | AU1792200A (pt) |
BR (1) | BR0008241A (pt) |
CA (1) | CA2358487C (pt) |
DE (1) | DE60016892T2 (pt) |
DK (1) | DK1140090T3 (pt) |
ES (1) | ES2234559T3 (pt) |
HK (1) | HK1042039B (pt) |
IL (1) | IL143903A (pt) |
PT (1) | PT1140090E (pt) |
SI (1) | SI1140090T1 (pt) |
TR (1) | TR200101892T2 (pt) |
WO (1) | WO2000040244A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999009981A1 (en) | 1997-08-21 | 1999-03-04 | P.N. Gerolymatos S.A. | Use of phanquinone for the treatment of alzheimer's disease |
AU2001250573A1 (en) * | 2000-04-28 | 2001-11-12 | Michel Xilinas | Treatment of pathological conditions influenced by the action of matrix metalloproteinases (mmps) using phanquinone |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1472257A (en) | 1973-09-10 | 1977-05-04 | Christiaens Sa A | Derivative of 4-hydroxy-5-azacoumarin |
US4845115A (en) * | 1986-12-17 | 1989-07-04 | Glaxo Group Limited | Method of medical treatment |
US5091391A (en) | 1990-08-16 | 1992-02-25 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method of resisting neurodegenerative disorders |
DE69227380T3 (de) | 1991-11-12 | 2007-01-11 | Prana Biotechnology Ltd., South Melbourne | Verfahren zur bestimmung und behandlung von alzheimer-krankheit |
US5866597A (en) * | 1993-03-19 | 1999-02-02 | Glaxo Wellcome Inc. | Use of triazine compounds for the treatment of memory and learning disorders |
US5792774A (en) * | 1996-02-21 | 1998-08-11 | Chiroscience Limited | Quinolones and their therapeutic use |
WO1997046526A1 (en) | 1996-06-07 | 1997-12-11 | Eisai Co., Ltd. | Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production |
IL128416A (en) | 1996-08-13 | 2004-06-01 | Gerolymatos P N Sa | Use of Clioquinol for the preparation of a pharmaceutical preparation for the treatment of Alzheimer's disease and pharmaceutical preparations containing it |
WO1998040071A1 (en) | 1997-03-11 | 1998-09-17 | The General Hospital Corporation | Identification of agents for use in the treatment of alzheimer's disease |
WO1999009981A1 (en) * | 1997-08-21 | 1999-03-04 | P.N. Gerolymatos S.A. | Use of phanquinone for the treatment of alzheimer's disease |
US5980914A (en) | 1997-08-22 | 1999-11-09 | P.N. Gerolymatos S.A. | Clioquinol for the treatment of Parkinson's disease |
US5994323A (en) | 1997-12-31 | 1999-11-30 | P.N. Gerolymatos S.A. | Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof |
-
2000
- 2000-01-06 TR TR2001/01892T patent/TR200101892T2/xx unknown
- 2000-01-06 PT PT00900025T patent/PT1140090E/pt unknown
- 2000-01-06 JP JP2000592001A patent/JP2002534386A/ja active Pending
- 2000-01-06 WO PCT/IB2000/000011 patent/WO2000040244A1/en not_active Application Discontinuation
- 2000-01-06 CA CA002358487A patent/CA2358487C/en not_active Expired - Fee Related
- 2000-01-06 DE DE60016892T patent/DE60016892T2/de not_active Expired - Fee Related
- 2000-01-06 AT AT00900025T patent/ATE285235T1/de not_active IP Right Cessation
- 2000-01-06 SI SI200030621T patent/SI1140090T1/xx unknown
- 2000-01-06 EP EP00900025A patent/EP1140090B1/en not_active Expired - Lifetime
- 2000-01-06 IL IL14390300A patent/IL143903A/en not_active IP Right Cessation
- 2000-01-06 BR BR0008241-4A patent/BR0008241A/pt not_active Application Discontinuation
- 2000-01-06 ES ES00900025T patent/ES2234559T3/es not_active Expired - Lifetime
- 2000-01-06 AR ARP000100046A patent/AR022215A1/es unknown
- 2000-01-06 AU AU17922/00A patent/AU1792200A/en not_active Abandoned
- 2000-01-06 DK DK00900025T patent/DK1140090T3/da active
-
2002
- 2002-03-15 US US10/098,922 patent/US7030136B2/en not_active Expired - Fee Related
- 2002-04-10 HK HK02102678.3A patent/HK1042039B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU1792200A (en) | 2000-07-24 |
DE60016892T2 (de) | 2005-12-15 |
HK1042039A1 (en) | 2002-08-02 |
CA2358487A1 (en) | 2000-07-13 |
DK1140090T3 (da) | 2005-04-18 |
PT1140090E (pt) | 2005-05-31 |
EP1140090A1 (en) | 2001-10-10 |
TR200101892T2 (tr) | 2001-11-21 |
CA2358487C (en) | 2008-11-18 |
US20030055078A1 (en) | 2003-03-20 |
IL143903A (en) | 2004-02-08 |
EP1140090B1 (en) | 2004-12-22 |
ES2234559T3 (es) | 2005-07-01 |
US7030136B2 (en) | 2006-04-18 |
SI1140090T1 (en) | 2005-06-30 |
WO2000040244A1 (en) | 2000-07-13 |
DE60016892D1 (de) | 2005-01-27 |
IL143903A0 (en) | 2002-04-21 |
HK1042039B (zh) | 2005-07-29 |
JP2002534386A (ja) | 2002-10-15 |
ATE285235T1 (de) | 2005-01-15 |
AR022215A1 (es) | 2002-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0959888T3 (da) | Anvendelse af det chelerende middel clioquinol til fremstillingen af et farmaceutisk præparat til behandlingen af Alzheimer's sygdom | |
HRP20020880B1 (en) | New pharmaceutical composition | |
BR0114610A (pt) | Composto, uso do mesmo, e, composição farmacêutica | |
BRPI0008228B8 (pt) | composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes | |
BR0109779A (pt) | Soluções moleculares hidrofìlicas dispersas de carvedilol | |
NO954996L (no) | Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS | |
EE200200202A (et) | Uudsed tritsüklilised ühendid, nende saamine ja kasutamine ravimi valmistamiseks, mis on ette nähtud HIV-nakkuse raviks, ning neid sisaldav farmatseutiline kompositsioon | |
BR0210489A (pt) | Formulação farmacêutica oral, processo para preparar a mesma, uso da mesa, e método para preparar um distúrbio cardiovascular em um paciente | |
ATE292453T1 (de) | Antivirale arznei | |
PT94521A (pt) | Processo para a preparacao de 5,11-di-hidro-6h-dipirido-{3,2-b:2',3'-e}{1,4}-diazepino-6-onas e tionas e de composicoes farmaceutica para o tratamento ou a profilaxia da sida | |
NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
WO2001062235A3 (en) | A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer | |
HUP0202776A2 (hu) | (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására | |
ATE114244T1 (de) | Pharmazeutische zusammensetzungen enthaltend fluticasonpropionat und oxikonazol oder dessen salz zur lokalen anwendung. | |
DK393188A (da) | Farmaceutisk praeparat til intranasal administrering | |
PT966285E (pt) | Utilizacao de (+)mefloquina para o tratamento da malaria | |
WO1990013542A1 (fr) | Medicament anti-hiv | |
BR9814945A (pt) | Utilização de fanquinona para o tratamento de doença de alzheimer, composição farmacêutica e kit | |
TR200102512T2 (tr) | Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı. | |
WO2000048445A3 (de) | Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit | |
SE0001916D0 (sv) | Novel formulation | |
BR0008241A (pt) | Utilização de fanquinona para a preparação deuma composição farmacêutica para o tratamentode enfraquecimento de memória e método detratamento | |
AU3278800A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence | |
AU2907800A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism | |
BR0308990A (pt) | Composição farmacêutica de eritromicina e seus derivados com sabor mascarado e processo de sua preparação |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10(VIII), 24 E 25 DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |